Novartis
OpenCalais Metadata: Ticker
Polakis to face Parliament’s ethics committee after battle royal with Georgiadis, who will sue him
Parliament Speaker Kostas Tasoulas has referred SYRIZA MP Pavlos Polakis to the legislature's Ethics Committee in the latest episode in the vendetta between the SYRIZA MP and Development Minister and New Democracy vice-president Adonis Georgiadis over charges that the latter as health minister received kickbacks from the pharmaceutical giant Novartis.
Lek planning EUR 83m investment in Ljubljana
Ljubljana – Lek, a Novartis-owned Slovenian drug maker, is planning an EUR 82.6 million investment in Ljubljana to set up a new production facility for liquid vials and pre-filled syringes. The government is expected to subsidise it with EUR 6.56 million, according to working documents prepared for government sessions.
- Read more about Lek planning EUR 83m investment in Ljubljana
- Log in to post comments
Swiss envoy to Turkey discusses prospects for sustainable planet
Switzerland's ambassador in Ankara said Nov. 24 that the international community aims to leave a sustainable world for children and future generations.
"We aim for a sustainable planet and a sustainable economy," Jean-Daniel Ruch told a meeting - Rethinking sustainable development: The social, environmental, economic value behind the healthcare industry - held in Ankara.
Relevant prosecutor extends anonymity to 2 witnesses whose claims triggered years of investigation against 10 politicians
A relevant magistrate in the financial crimes prosecutor's office on Tuesday extended, by two years, the protected status for two controversial witnesses who had leveled allegations against 10 top office-holders, including past prime ministers, of receiving kickbacks from Novartis' Greek subsidiaries.
Demonstrating the conspiracy scheme against Stavros Papastavrou
Advanced breast cancer medicine now available in Slovenia
Ljubljana – Alpelizib, the only targeted therapy for a specific type of advanced breast cancer, is now accessible to patients in Slovenia, making it one of the few countries where it is available. The Institute of Oncology already started treating patients in the compassionate use programme before the drug was registered.
Στη Θεσσαλονίκη παρουσιάζει το βιβλίο του ο Ανδρέας Λοβέρδος
Το βιβλίο είναι μια προσωπική εξομολόγηση του Ανδρέα Λοβέρδου για την υπόθεση Novartis
Members of Greek judiciary test positive for Covid-19
Multiple members of Greece's judiciary have tested positive for Covid-19 in recent days, Kathimerini has learned. This includes several prominent jurists as well as an unknown number of positive cases that were diagnosed at the Athens Court of First Instance.
Novartis invested EUR 204m in Slovenia in 2020
Ljubljana – The Swiss pharma giant Novartis continued to invest in its R&D and production capacities in Slovenia through its subsidiaries Lek, Sandoz and Novartis Pharma Services last year. Despite the Covid-19 epidemic, it invested EUR 204 million in the country, show figures presented on Tuesday.
- Read more about Novartis invested EUR 204m in Slovenia in 2020
- Log in to post comments
EU goal of full vaccine coverage by end-2021 within reach, says health commissioner
The European Union's target to have secured enough vaccinations against the novel coronavirus to inoculate every citizen in the bloc by the end of 2021 is within reach, Commissioner for Health and Food Safety Stella Kyriakides told Kathimerini in Brussels on Monday.